Clinical Trial Update: Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing bevacizumab with docetaxel and gemcitabine in stage IIIB, stage IV, or recurrent non-small cell lung cancer has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Nathan Pennell, MD, PhD | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-02-04